Literature DB >> 33642998

D1R- and D2R-Medium-Sized Spiny Neurons Diversity: Insights Into Striatal Vulnerability to Huntington's Disease Mutation.

Guendalina Bergonzoni1, Jessica Döring1, Marta Biagioli1.   

Abstract

Huntington's disease (HD) is a devastating neurodegenerative disorder caused by an aberrant expansion of the CAG tract within the exon 1 of the HD gene, HTT. HD progressively impairs motor and cognitive capabilities, leading to a total loss of autonomy and ultimate death. Currently, no cure or effective treatment is available to halt the disease. Although the HTT gene is ubiquitously expressed, the striatum appears to be the most susceptible district to the HD mutation with Medium-sized Spiny Neurons (MSNs) (D1R and D2R) representing 95% of the striatal neuronal population. Why are striatal MSNs so vulnerable to the HD mutation? Particularly, why do D1R- and D2R-MSNs display different susceptibility to HD? Here, we highlight significant differences between D1R- and D2R-MSNs subpopulations, such as morphology, electrophysiology, transcriptomic, functionality, and localization in the striatum. We discuss possible reasons for their selective degeneration in the context of HD. Our review suggests that a better understanding of cell type-specific gene expression dysregulation within the striatum might reveal new paths to therapeutic intervention or prevention to ameliorate HD patients' life expectancy.
Copyright © 2021 Bergonzoni, Döring and Biagioli.

Entities:  

Keywords:  D1R; D2R; Huntington’s disease; medium-sized spiny neurons; neurodegeneration; selective vulnerability; striatum

Year:  2021        PMID: 33642998      PMCID: PMC7902492          DOI: 10.3389/fncel.2021.628010

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  115 in total

Review 1.  Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release.

Authors:  George V Rebec
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

Review 2.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

3.  Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.

Authors:  Kirupa Sathasivam; Andreas Neueder; Theresa A Gipson; Christian Landles; Agnesska C Benjamin; Marie K Bondulich; Donna L Smith; Richard L M Faull; Raymund A C Roos; David Howland; Peter J Detloff; David E Housman; Gillian P Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

4.  Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.

Authors:  Y P Deng; R L Albin; J B Penney; A B Young; K D Anderson; A Reiner
Journal:  J Chem Neuroanat       Date:  2004-06       Impact factor: 3.052

5.  Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.

Authors: 
Journal:  Cell       Date:  2015-07-30       Impact factor: 41.582

6.  Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset.

Authors:  Meera Swami; Audrey E Hendricks; Tammy Gillis; Tiffany Massood; Jayalakshmi Mysore; Richard H Myers; Vanessa C Wheeler
Journal:  Hum Mol Genet       Date:  2009-05-23       Impact factor: 6.150

7.  Quantification of age-dependent somatic CAG repeat instability in Hdh CAG knock-in mice reveals different expansion dynamics in striatum and liver.

Authors:  Jong-Min Lee; Ricardo Mouro Pinto; Tammy Gillis; Jason C St Claire; Vanessa C Wheeler
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

8.  Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches.

Authors:  Ricardo Mouro Pinto; Ella Dragileva; Andrew Kirby; Alejandro Lloret; Edith Lopez; Jason St Claire; Gagan B Panigrahi; Caixia Hou; Kim Holloway; Tammy Gillis; Jolene R Guide; Paula E Cohen; Guo-Min Li; Christopher E Pearson; Mark J Daly; Vanessa C Wheeler
Journal:  PLoS Genet       Date:  2013-10-31       Impact factor: 5.917

Review 9.  Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease.

Authors:  Laetitia Francelle; Laurie Galvan; Emmanuel Brouillet
Journal:  Front Cell Neurosci       Date:  2014-09-26       Impact factor: 5.505

10.  Early alteration of epigenetic-related transcription in Huntington's disease mouse models.

Authors:  Irati Hervás-Corpión; Deisy Guiretti; Manuel Alcaraz-Iborra; Román Olivares; Antonio Campos-Caro; Ángel Barco; Luis M Valor
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

View more
  2 in total

Review 1.  Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease.

Authors:  Shinichi Takahashi; Kyoko Mashima
Journal:  Antioxidants (Basel)       Date:  2022-01-17

2.  Amyloid-β oligomers in the nucleus accumbens decrease motivation via insertion of calcium-permeable AMPA receptors.

Authors:  Changyong Guo; Di Wen; Yihong Zhang; Richie Mustaklem; Basil Mustaklem; Miou Zhou; Tao Ma; Yao-Ying Ma
Journal:  Mol Psychiatry       Date:  2022-02-02       Impact factor: 13.437

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.